Isotretinoin use and the risk of inflammatory bowel disease

American Journal of Gastroenterology

Volumn 106, Issue 5, 2011, Pages 1000-1002

  Thakrar, B T ^a   Robinson, N J ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ISOTRETINOIN;

ACNE; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; ENTERITIS; HUMAN; LETTER; PRIORITY JOURNAL; RISK; ULCERATIVE COLITIS;

ACNE VULGARIS; DERMATOLOGIC AGENTS; HUMANS; INFLAMMATORY BOWEL DISEASES; ISOTRETINOIN; RISK;

EID: 79955618320     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2011.28     Document Type: Letter

References (5)

1. Crockett S, Porter C, Martin C et al. Isotretinoin use and the risk of inflammatory bowel disease: a case-control study. Am J Gastroenterol 2010; 105: 1986-1993.
2. Rothman K, Greenland S, Lash T. Modern Epidemiology, 3rd edn. Lippincott Williams & Wilkin: Wolters Kluwer Health, Philadelphia, 2008.
3. Lavarreda S, Gatchell M, Ponce N et al. Switching Health insurance and its effect on access to physician services. Med Care 2008; 46: 1055-1063.
4. Cunningham P, Kohn L. Health plan switching: choice or circumstances? Health Affair 2000; 19: 158-164.
5. Bernstein C, Nugent Z, Longobardi T et al. Isotretinoin is not associated with inflammatory bowel disease: a population based case-control study. Am J Gastroenterol 2009; 104: 2774-2778.